Z
ZWI Therapeutics
ZWI Therapeutics is a biotech startup in its early stages, focused on developing protein therapeutics with an innovative polymer
About ZWI Therapeutics
ZWI Therapeutics, a biotechnology firm established in 2020, is focused on advancing protein therapeutics through the application of its proprietary polymer technology. The company was co-founded by Dr. Bob Langer and Dr. Shaoyi Jiang, who currently serves as the Robert Langer '70 Family and Friends Professor at Cornell University and is a board member. The firm is headquartered in Watertown, Massachusetts, and also has operations in Waltham, MA.
The core of ZWI's strategy revolves around its patented polycarboxybetaine polymer. This technology is engineered to create protein-polymer conjugates that demonstrate superior safety and efficacy compared to existing therapeutics that use polyethylene glycol (PEG). Preclinical studies in animal models have shown that ZWI's polycarboxybetaine conjugates exhibit low to no immunogenicity and favorable pharmacokinetics when contrasted with their PEG counterparts, suggesting potential for enhanced clinical durability and safety. This polymer platform has broad applicability, extending to the development of nanoparticles and hydrogels, particularly for cellular therapies.
The company's business model includes developing its own pipeline of drug candidates while also out-licensing its technology to other pharmaceutical companies for specific development programs. Its lead program, ZWI-001, is a uricase-polycarboxybetaine conjugate being developed for the treatment of hyperuricemia in patients with severe gout, a market with significant unmet medical needs. This program has achieved preclinical proof of concept, and following a productive INTERACT meeting with the FDA, the company is advancing toward an Investigational New Drug (IND) filing.
In January 2024, ZWI Therapeutics successfully closed a $10 million Series A financing round with investors Co-win Ventures and Sherpa Healthcare Partners. Concurrently, the company strengthened its leadership by appointing Dr. Ed Mascioli as Chief Executive Officer and adding seasoned biopharmaceutical executives Dr. Larry Miller and Dr. Ron Cohen to its Board of Directors.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 55.1/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Spinout, Polymers, Biotech and Pharma, proteomics, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Jan 2024 | — | — | Undisclosed | ↗ |
| SERIES AOther financing | Mar 2021 | $10M | $40M | Cowin Venture | — |
Growth signals
Latest recorded traffic for ZWI Therapeutics is 300 monthly website visits, up 7.1% over the last three months. ZWI Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
ZWI Therapeutics in the Watertown ecosystem
The ZWI Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Cowin Venture
Other known investors1 additional known investor
University of Washington
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about ZWI Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ZWI Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









